Key result
PKC activation inhibits cAMP-induced activation of BKCa channels and causes pulmonary vasoconstriction via phosphodiesterase in a rat model of pulmonary hypertension.
Why the study?
Do phosphodiesterase inhibitors reverse PKC-mediated inhibition of BKCa channels and vasoconstriction in hypertensive pulmonary arterial smooth muscle?
Do phosphodiesterase inhibitors reverse PKC-mediated inhibition of BKCa channels and vasoconstriction in hypertensive pulmonary arterial smooth muscle?
PDE inhibitors reverse PKC-mediated inhibition of BKCa channels and prevent pulmonary vasoconstriction, providing mechanistic support for their use in pulmonary hypertension.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for PKC-BKCa modulation in pulmonary hypertension models; leaves open human translation.
BKCa channels regulate pulmonary arterial pressure, and protein kinase C (PKC) inhibits BK(Ca) channels, but little is known about PKC-mediated modulation of BKCa channel activity in pulmonary arterial smooth muscle. Studies were carried out to determine mechanisms of PKC modulation of BKCa channel activity in pulmonary arterial smooth muscle cells (PASMC) of the fawn-hooded rat (FHR), an animal model of pulmonary hypertension. Forskolin opened BKCa channels in FHR PASMC, which was blocked by PKC activation, and reversed by the phosphodiesterase (PDE) inhibitors IBMX, milrinone, and zaprinast. PDE inhibition also blocked the vasoconstrictor response to PKC activation in FHR pulmonary arteries. These results indicate that PKC inhibits cAMP-induced activation of BKCa channels and causes pulmonary vasoconstriction in hypertensive pulmonary arterial smooth muscle via PDE, which further suggests PDE inhibitors for treatment of pulmonary hypertension.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2008) studied Pulmonary hypertension. PKC activation and PDE inhibitors was evaluated on BKCa channel activity and vasoconstrictor response. PKC activation inhibits cAMP-induced activation of BKCa channels and causes pulmonary vasoconstriction via phosphodiesterase in a rat model of pulmonary hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: